How AI is Transforming Clinical Trials

In this ISSUE

Patient Experience Comes to Drug Development

eClinical Technology Considerations for Cell and Gene Therapy Studies: Case Study Snapshots of Personalized Medicine

CMC Considerations for Gene Therapy and Regenerative Medicine Studies

Artificial Intelligence

How AI is Transforming Clinical Trials: A Look Into the Code

Krishnan Nandabalan, CEO of InveniAI, discusses how artificial intelligence is shifting the clinical trial paradigm in studies for areas like oncology and the central nervous system.
... /Read more/

Successful Early Phase Drug Development of mAb Drugs
Europe: Thursday, September 26, 2019 at 3pm BST | 4pm CEST
North America: Thursday, October 3, 2019 at 11am EDT | 10am CDT | 8am PDT

Patient Centricity

Patient Centricity Goes Global

Barbara Lopez Kunz, Global Chief Executive at the Drug Information Association discusses how involvement of patients in healthcare is critical for success.
... /Read more/

Calendar

/ 3^rd Annual Medical Writers Summit — 9/25–9/26 /

/ 4^th Annual Lay Summaries Summit — 9/25–9/26 /

/ 16th Annual Patient Summit USA – 10/2–10/3 /

/ Rare Diseases & Orphan Products Breakthrough Summit – 10/21–10/22 /

Risk Management

Using AI & Machine Learning to Better Understand Data and Manage Risk

Basheer Hawwash, Principal Data Scientist at Remarque Systems Inc., writes of the potential artificial intelligence, more specifically machine learning, has to transform clinical trials.
... /Read more/

Industry News

Latest in People and Business News

The latest happenings in the clinical trials world, all in one place.
... /Read more/

Drug Pricing

Down with Drug Reference Pricing!

PhRMA in Europe cries of trailing the US after adopting reference pricing.
... /Read more/

Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
tbaker@mmhgroup.com

website / blog / advertise / subscribe